glutathione switch persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition Plasticity, signaling, and metabolic rewiring
Plasticity, signaling, and metabolic rewiring in melanoma persister cells Communications Biology Cancer drug tolerant persister cells: from biological questions to clinical opportunities Nature Reviews Cancer Drug tolerant persister cancer cells are vulnerable to GPX4 inhibition PMC Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics Discover Oncology Springer Nature Link
Pay in 4 interest-free payments of $6.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



